List of Our Studies

All Studies Browse the full index of research entries.

Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals

Valdivia A, Ly J, Gonzalez L, Hussain P, Aing T, Islamoglu H, et al. July, 2015 in the Journal of Interferon & Cytokine Research · 2015

Furthermore, we demonstrate that supplementing individuals with HIV infection for 13 weeks with liposomal GSH (lGSH) resulted in a significant increase in the levels of TH1 cytokines, IL-1?, IL-12, IFN-?, and TNF-?. lGSH supplementation in individuals with HIV infection also resulted in a substantial decrease in the levels of free radicals and immunosuppressive cytokines, IL-10 […]

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes

To K, Cao R, Yegiazaryan A, Owens J, Nguyen T, Sasaninia K, et al. 2021 in Frontiers in Cellular Infection Microbiology · 2021

We report that L-GSH supplementation for 3 months in people with T2DM was able to reduce the levels of oxidative stress in all blood components and prevent depletion of glutathione (GSH) in this population known to be GSH deficient.

Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals

Valdivia A, Ly J, Gonzalez L, Hussain P, Aing T, Islamoglu H, et al. July, 2015 in the Journal of Interferon & Cytokine Research · 2015

Furthermore, we demonstrate that supplementing individuals with HIV infection for 13 weeks with liposomal GSH (lGSH) resulted in a significant increase in the levels of TH1 cytokines, IL-1?, IL-12, IFN-?, and TNF-?. lGSH supplementation in individuals with HIV infection also resulted in a substantial decrease in the levels of free radicals and immunosuppressive cytokines, IL-10 […]

Glutathione Supplementation Improves Macrophage Functions in HIV

Morris D, Guerra C, Khurasany M, Guilford F, Saviola B, Huang Y, et al. May, 2013 in the Journal Interferon and Cytokine Research · 2013

The results indicate that HIV infection leads to increased production of free radicals and decreased production of GCLC resulting in depletion of rGSH and this may lead, in part, to the loss of innate immune function observed in HIV patients.

Oral pretreatment with liposomal glutathione attenuates reperfusion injury in rabbit isolated hearts

Lauver DA, Kaissarian NM, Lucchesi BR. December, 2011 in the Journal of Cardiovascular Pharmacology · 2011

Hearts from lipGSH-treated rabbits exhibited better recovery of left ventricular contractile function during reperfusion and had attenuated oxidative damage. Furthermore, hearts from lipGSH-treated animals had increased myocardial tissue levels of GSH demonstrating effective absorption of lipGSH.

A clinical trial of glutathione supplementation in autism spectrum disorders

Janet K Kern, David A Geier. December, 2011 in Medical Science Monitor · 2011

The results suggest that oral … glutathione supplementation may have some benefit in improving some of the transsulfuration metabolites. Future studies among subjects diagnosed with an ASD should further explore the pharmacokinetics of glutathione supplementation and evaluate the potential effects of glutathione supplementation upon clinical symptoms.

Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells

Gail D Zeevalk, Laura P Bernard, F T Guilford. October, 2010 in Neurochemical Research · 2010

No toxicity was observed with the liposomal preparation at 200-fold the EC(50) for repletion. These findings indicate that glutathione supplied in a liposomal formulation holds promise as a potential therapeutic for neuronal maintenance. PMID: Read the Article

Aminothiol receptors for decorporation of intravenously administered (60)Co in the rat

Tatiana G Levitskaia, James E Morris. January, 2010 in Health Physics Journal · 2007

Liposomal encapsulation was found to markedly enhance the oral bioavailability of GSH compared to non-formulated GSH. The oral administration of liposomal GSH reduced (60)Co levels in nearly all tissues by 12-43% compared to that observed for non-formulated GSH. Efficacy of oral Cys was only slightly reduced in comparison with intravenous Cys.